磷酸肌酸钠联合利巴韦林治疗小儿病毒性心肌炎的临床疗效及其对患儿心肌酶水平的影响

doi:10.13481/j.1671-587x.20180126

摘要/Abstract

摘要： 目的：探讨磷酸肌酸钠联合利巴韦林治疗病毒性心肌炎患儿临床疗效，并阐述其对患儿心肌酶水平的影响。方法：选取病毒性心肌炎患儿96例，按照随机数字表法分为观察组和对照组，每组48例。2组患儿就诊后均行心肌酶谱和肌钙蛋白I（cTnI）等检测，同时行抗感染、补充电解质及营养心肌等支持治疗，并均给予利巴韦林静脉滴注治疗。在此基础上，观察组患者给予磷酸肌酸钠静滴，疗程均为14d。治疗后比较2组患儿治疗总有效率和治疗前后心肌酶及cTnI水平和心电图改善情况。结果：观察组患儿治疗总有效率为87.50%（42/48），对照组患儿治疗总有效率为70.83%（34/48），组间比较差异有统计学意义（χ²=4.04，P=0.04）；2组患儿治疗后乳酸脱氢酶（LDH）、羟丁酸脱氢酶（HBDH）、天冬氨酸氨基转移酶（AST）、肌酸磷酸激酶（CPK）、肌酸磷酸激酶同工酶（CK-MB）和cTnI水平均明显低于治疗前（P<0.05），且观察组患儿上述指标水平均明显低于对照组（P<0.05）；观察组患儿心电图改善总有效率（89.58%）高于对照组（72.92%），组间比较差异有统计学意义（χ²=4.38，P=0.04）。结论：磷酸肌酸钠联合利巴韦林治疗病毒性心肌炎患儿总有效率更高，且能明显降低患儿心肌酶水平，改善心功能，值得临床推广。

关键词: 病毒性心肌炎, 心电图, 利巴韦林, 磷酸肌酸钠, 心肌酶

Abstract: Objective: To investigate the clinical efficacy of creatine phosphate sodium combined with ribavirin in the treatment of infantile viral myocarditis,and to elucidate its mechanism of the effects on myocardial enzyme levels in the children. Methods: A total of 96 children with viral myocarditis were selected; according to the random number grouping method,they were divided into observation group and control group (n=48).The myocardial enzymes and cardiac troponin I(cTnI) of the patients in two groups were detected,and anti-infection,supplementation of electrolytes,and nutritional support for myocardial treatment were performed; then intravenous infusion therapy of ribavirin was used.On this basis,the patients in observation group were given intravenous infusion of creatine phosphate sodium for 14 d.After treatment,the total effective rate of treatment of the patients in two groups,the levels of myocardial enzymes and cTnI and electrocardiogram were compared before and after treatment. Results: The total effective rate of the patients in observation group was 87.50% (42/48),and it was 70.83% (34/48) in control group;there was significant difference (χ²=4.04,P=0.04).After treatment,the levels of lactate dehydrogenase (LDH),hydroxybutyrate dehydrogenase (HBDH),aspartate transaminase (AST),creatine phosphokinase (CPK),creatine kinase isoenzyme-MB (CK-MB) and CTnI of the patients in two groups after treatment were lower than before treatment (P<0.05).The indicators mentioned above of patients in observation group were lower than those in control group(P<0.05).The total improvement rate of electrocardiogram in the observation group (89.58%) was significantly higher than that in control group (72.92%),and the difference was statistically significant (χ²=4.38,P=0.04). Conclusion: The total effective rate of creatine phosphate sodium combined with ribavirin in the treatment of infantile viral myocarditis is higher,and they can significantly reduce the levels of myocardial enzymes and improve the cardiac function; it is worth to apply in the clinical treatment.

Key words: creatine phosphate sodium, myocardial enzymes, viral myocarditis, ribavirin, electrocardiogram

中图分类号:

R725.4

李玉佳, 卢伟, 杜侃. 磷酸肌酸钠联合利巴韦林治疗小儿病毒性心肌炎的临床疗效及其对患儿心肌酶水平的影响[J]. 吉林大学学报(医学版), 2018, 44(01): 137-141.

LI Yujia, LU Wei, DU Kan. Clinical efficacy of creatine phosphate sodium combined with ribavirin in treating infantile viral myocarditis and its effect on myocardial enzyme levels in children[J]. Journal of Jilin University Medicine Edition, 2018, 44(01): 137-141.

参考文献

[1] 袁泉,张萍.磷酸肌酸钠联合心肌康颗粒治疗小儿病毒性心肌炎实效性分析[J].重庆医学,2016,45(10):1343-1344,1347.
[2] Takahashi T,Saegusa S,Sumino H,et al.Adiponectin replacement therapy attenuates myocardial damage in leptin-deficient mice with viral myocarditis[J].J Int Med Res,2005,33(2):207-214.
[3] 金剑,王伟杰,陆巧英,等.T注射用黄芪多糖辅助治疗小儿急性病毒性心肌炎的临床疗效及对心肌酶的影响[J].中国妇幼保健,2016,31(11):2305-2307.
[4] Lindner D,Li J,Savvatis K,et al.Cardiac fibroblasts aggravate viral myocarditis:cell specific coxsackievirus B3 replication[J].Mediators Inflamm,2014,2014(10):519528.
[5] 童人杰,赵蓓,解雪君.磷酸肌酸联合免疫球蛋白治疗小儿病毒性心肌炎疗效观察[J].儿科药学杂志,2016,22(10):24-26.
[6] 王祥,田兆方.热毒宁注射液治疗小儿病毒性心肌炎临床疗效的随机对照研究[J].中医药学报,2016,44(5):98-101.
[7] Zhou L,He X,Gao B,et al.Inhibition of histone deacetylase activity aggravates coxsackievirus B3-induced myocarditis by promoting viral replication and myocardial apoptosis[J].J Virol, 2015,89(20):10512-10523.
[8] Pollack A,Kontorovich AR,Fuster V,et al.Viral myocarditis-diagnosis,treatment options,and current controversies[J].Nature Rev Cardiol,2015,12(11):670-680.
[9] Zha X,Yue Y,Dong N,et al.Endoplasmic reticulum stress aggravates viral myocarditis by raising inflammation through the IRE1-associated NF-κB pathway[J].Can J Cardiol,2015,31(8):1032-1040.
[10] 王翠红.喜炎平注射液联合磷酸肌酸钠治疗小儿病毒性心肌炎的临床研究[J].现代药物与临床,2017,32(6):1039-1042.
[11] Cheng Z,Li-Sha G,Yue-Chun L.Autonomic nervous system in viral myocarditis:pathophysiology and therapy[J].Curr Pharm Des,2016,22(4):485.
[12] 谢志玉,陈明.心达康片联合常规治疗对小儿病毒性心肌炎的疗效观察[J].中国药师,2016,19(8):1518-1519.
[13] Li M,Yan K,Wei L,et al.Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis[J].Antiviral Res,2015,123:50-61.
[14] Jiang Y,Zhu R,Luo L,et al.Recombinant mouse u03b2-defensin 3 protects against coxsackievirus B3-induced myocarditis in Mice[J].Intervirology,2015,58(6):343-349.
[15] 文丹宁,胡继川.甘草酸二铵注射液治疗小儿重症暴发性病毒性心肌炎的疗效及对炎症因子、CK-MB和肌钙蛋白的影响[J].中国临床研究,2017,30(2):162-164.
[16] Rached-D'Astous S,Boukas I,Anne Fournier A,et al.Coronary artery dilatation in viral myocarditis mimics coronary artery findings in kawasaki disease[J].Pediat Cardiol,2016,37(6):1148-1152.
[17] An B,Liu X,Li G,et al.IL-37 ameliorates coxsackievirus B3-induced viral myocarditis by modulating the Th17/Treg immune response[J].J Cardiovascu Pharmacol,2017,69(5):305-313.
[18] 李彩虹.磷酸肌酸钠、维生素C联合抗病毒治疗对病毒性心肌炎患儿心肌损伤的保护作用[J].海南医学院学报,2016,22(20):2482-2485.